MIT Libraries logoDSpace@MIT

MIT
View Item 
  • DSpace@MIT Home
  • MIT Open Access Articles
  • MIT Open Access Articles
  • View Item
  • DSpace@MIT Home
  • MIT Open Access Articles
  • MIT Open Access Articles
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Repurposing existing medications for coronavirus disease 2019: protocol for a rapid and living systematic review

Author(s)
Geisler, Benjamin P.; Zahabi, Lara; Lang, Adam Edward; Eastwood, Naomi; Tennant, Elaine; Lukic, Ljiljana; Sharon, Elad; Chuang, Hai-Hua; Kang, Chang-Berm; Clayton-Johnson, Knakita; Aljaberi, Ahmed; Yu, Haining; Bui, Chinh; Le Mau, Tuan; Li, Wen-Cheng; Teodorescu, Debbie; Hinske, Ludwig Christian; Sun, Dennis L.; Manian, Farrin A.; Dunn, Adam G.; ... Show more Show less
Thumbnail
Download13643_2021_Article_1693.pdf (500.3Kb)
Publisher with Creative Commons License

Publisher with Creative Commons License

Creative Commons Attribution

Terms of use
Creative Commons Attribution https://creativecommons.org/licenses/by/4.0/
Metadata
Show full item record
Abstract
Background: Coronavirus disease 2019 (COVID-19) has no confirmed specific treatments. However, there might be in vitro and early clinical data as well as evidence from severe acute respiratory syndrome and Middle Eastern respiratory syndrome that could inform clinicians and researchers. This systematic review aims to create priorities for future research of drugs repurposed for COVID-19. Methods: This systematic review will include in vitro, animal, and clinical studies evaluating the efficacy of a list of 34 specific compounds and 4 groups of drugs identified in a previous scoping review. Studies will be identified both from traditional literature databases and pre-print servers. Outcomes assessed will include time to clinical improvement, time to viral clearance, mortality, length of hospital stay, and proportions transferred to the intensive care unit and intubated, respectively. We will use the GRADE methodology to assess the quality of the evidence. Discussion: The challenge posed by COVID-19 requires not just a rapid review of drugs that can be repurposed but also a sustained effort to integrate new evidence into a living systematic review. Trial registration: PROSPERO 2020 CRD42020175648
Date issued
2021-05
URI
https://hdl.handle.net/1721.1/130574
Department
Massachusetts Institute of Technology. Device Research Laboratory
Journal
Systematic Reviews
Publisher
Springer Science and Business Media LLC
Citation
Geisler, Benjamin P. et al. "Repurposing existing medications for coronavirus disease 2019: protocol for a rapid and living systematic review." Systematic Reviews 10, 1 (May 2021): 143 © 2021 The Author(s)
Version: Final published version
ISSN
2046-4053

Collections
  • MIT Open Access Articles

Browse

All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

My Account

Login

Statistics

OA StatisticsStatistics by CountryStatistics by Department
MIT Libraries
PrivacyPermissionsAccessibilityContact us
MIT
Content created by the MIT Libraries, CC BY-NC unless otherwise noted. Notify us about copyright concerns.